Thus, IL‐1β and lactate mediate the feedback crosstalk between Mφ and tumor cells to weaken antitumor immunity, designing a synergistic antitumor effect when ICB is combined with IL‐1β blockade. The gene discussed is IL1B; the disease is neoplasm.